What is the level of liabilities of Evolus this year?
Evolus has a debt balance of 227.05 M USD this year.
Evolus Liabilities 2025
Evolus Liabilities
227.05 M USD
Ticker
EOLS
ISIN
US30052C1071
WKN
A2JDYX
In 2025, Evolus's total liabilities amounted to 227.05 M USD, a 8.28% difference from the 209.69 M USD total liabilities in the previous year.
Evolus Aktienanalyse
What does Evolus do?
Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Evolus's Liabilities
Evolus's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Evolus's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Evolus's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Evolus's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Evolus’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Evolus stock
What were the liabilities of Evolus compared to the previous year?
The liabilities of Evolus have increased by 8.28% increased compared to the previous year.
What are the consequences of high debt for investors of Evolus?
High liabilities can pose a risk for investors of Evolus, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Evolus?
Low liabilities mean that Evolus has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Evolus affect the company?
An increase in liabilities of Evolus can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Evolus affect the company?
A decrease in the liabilities of Evolus can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Evolus?
Some factors that can influence the liabilities of Evolus include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Evolus so important for investors?
The liabilities of Evolus are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Evolus take to modify the liabilities?
To change its liabilities, Evolus can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Evolus pay?
Over the past 12 months, Evolus paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Evolus is expected to pay a dividend of 0 USD.
What is the dividend yield of Evolus?
The current dividend yield of Evolus is .
When does Evolus pay dividends?
Evolus pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Evolus?
Evolus paid dividends every year for the past 0 years.
What is the dividend of Evolus?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Evolus located?
Evolus is assigned to the 'Health' sector.
Wann musste ich die Aktien von Evolus kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Evolus from 6/20/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/20/2025.
When did Evolus pay the last dividend?
The last dividend was paid out on 6/20/2025.
What was the dividend of Evolus in the year 2024?
In the year 2024, Evolus distributed 0 USD as dividends.
In which currency does Evolus pay out the dividend?
The dividends of Evolus are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Evolus stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Evolus
Our stock analysis for Evolus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Evolus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
